Hematopoietic stem cells

OTHER3 trials

Sponsors

Nantes University Hospital, Radboud Universitair Medisch Centrum, Academisch Medisch Centrum

Conditions

Cardiovascular diseaseGraft Versus Host DiseaseHematologic Malignancyfamilial hypercholesterolemia genetic elevated 'bad' cholesterol

Phase 2

Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation

RecruitingNCT06252870

Nantes University HospitalGraft Versus Host Disease, Hematologic Malignancy

Start: 2024-07-18End: 2028-07-18Target: 82Updated: 2026-01-26

Unknown Phase

Determination of phenotypic and epigenetic *trained immunity* characteristics of hematopoietic stem and progenitor cells in patients with established atherosclerosis, a proof-of-principle study

Active, not recruitingNL-OMON43290

Radboud Universitair Medisch CentrumCardiovascular disease

Start: 2017-07-20Target: 30Updated: 2024-02-28

To study the effect of LDL-cholesterol and LDL-cholesterol lowering on hematopoietic stem cells and circulating immune cells in familial hypercholesterolemia patients.

Active, not recruitingNL-OMON47323

Academisch Medisch Centrumfamilial hypercholesterolemia genetic elevated 'bad' cholesterol

Start: 2017-07-05Target: 50Updated: 2024-02-28